Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections. J Clin Oncol 1990 Mar;8(3):453-9

Date

03/01/1990

Pubmed ID

2307989

DOI

10.1200/JCO.1990.8.3.453

Abstract

One hundred nine consecutive episodes of septicemia were retrospectively evaluated in 61 children with malignancy. In addition, the records of all pediatric oncology patients who received high-dose cytarabine (HDAC) chemotherapy were reviewed. Gram-positive organisms accounted for 82.6% of the septicemic episodes. In the total group, coagulase-negative staphylococci and viridans streptococci accounted for 35.8% and 28.4% of the episodes, respectively. In granulocytopenic patients, viridans streptococci were the most common pathogens (36.8%). In the subset of patients who received HDAC, 62.5% of the septicemic episodes were caused by viridans streptococci. Pulmonary complications developed in nine (29%) of the total cases of viridans streptococcal sepsis, whereas these complications occurred in only eight (10.3%) of the septic episodes caused by other organisms. In patients who had viridans septicemia, prior treatment with HDAC did not increase the incidence of pulmonary complications. In septic children with malignancy, our results demonstrate a high incidence of gram-positive organisms, including viridans streptococci, which were once regarded as culture contaminants.

Author List

Weisman SJ, Scoopo FJ, Johnson GM, Altman AJ, Quinn JJ

Author

Steven J. Weisman MD Professor in the Anesthesiology department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Adolescent
Adult
Agranulocytosis
Child
Child, Preschool
Cytarabine
Female
Humans
Infant
Lung Diseases
Male
Neoplasms
Retrospective Studies
Risk Factors
Sepsis
Streptococcal Infections
jenkins-FCD Prod-484 8aa07fc50b7f6d102f3dda2f4c7056ff84294d1d